Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6317436B2 - - Google Patents
[go: Go Back, main page]

JPS6317436B2 - - Google Patents

Info

Publication number
JPS6317436B2
JPS6317436B2 JP54038438A JP3843879A JPS6317436B2 JP S6317436 B2 JPS6317436 B2 JP S6317436B2 JP 54038438 A JP54038438 A JP 54038438A JP 3843879 A JP3843879 A JP 3843879A JP S6317436 B2 JPS6317436 B2 JP S6317436B2
Authority
JP
Japan
Prior art keywords
deoxyribonuclease
dna
sepharose
extract
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54038438A
Other languages
Japanese (ja)
Other versions
JPS55131389A (en
Inventor
Hideyuki Tanaka
Hideyuki Hasegawa
Takeshi Matsuo
Buichi Horio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amano Enzyme Inc
Original Assignee
Amano Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amano Pharmaceutical Co Ltd filed Critical Amano Pharmaceutical Co Ltd
Priority to JP3843879A priority Critical patent/JPS55131389A/en
Publication of JPS55131389A publication Critical patent/JPS55131389A/en
Publication of JPS6317436B2 publication Critical patent/JPS6317436B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Description

【発明の詳細な説明】 本発明は、哺乳動物膵臓抽出物からデオキシリ
ボヌクレアーゼをきわめて簡易かつ高純度に精
製する方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an extremely simple method for purifying deoxyribonuclease from a mammalian pancreatic extract to a high degree of purity.

一般に、デオキシリボヌクレアーゼは、核酸
関係の学問研究上の利用のみならず、試薬、医薬
上の応用が期待されている有用物質であるが、哺
乳動物の膵臓から精製するに際しては、膵臓中に
含まれる種々の夾雑蛋白質、特に多量に含まれる
蛋白分解酵素であるトリプシンを除去することが
困難である。トリプシンが混在すると、その作に
より、一般的な精製法であるイオン交換クロマト
グラフイーなどの方法によりデオキシリボヌクレ
アーゼを膵臓抽出物より精製しようとしても、
デオキシリボヌクレアーゼが容易に分解され、
その結果著しい収率の低下となつてしまうのであ
つた。
In general, deoxyribonuclease is a useful substance that is expected to be used not only in academic research related to nucleic acids but also as a reagent and in medicine. It is difficult to remove various contaminant proteins, especially trypsin, which is a proteolytic enzyme contained in large amounts. If trypsin is present in the mixture, attempts to purify deoxyribonuclease from pancreatic extracts using common purification methods such as ion-exchange chromatography will fail.
easily degraded by deoxyribonuclease,
As a result, the yield was significantly reduced.

近年、酵素精製法の手段としてアフイニテイー
クロマトグラフイーが発達し、膵臓中よりデオキ
シリボヌクレアーゼを精製するのに、このアフ
イニテイークロマトグラフイーの応用を試みた例
がある。即ち、J.C.Schabort、Journal of
Chromatography.、Vol73、253〜256(1972)に
記載されている方法においては、ブロムシアン活
性化セフアロースにデオキシリボ核酸を固定化し
たデオキシリボ核酸固定化アガロース(以下
DNA−Sepharoseと云う)を用いてデオキシリ
ボヌクレアーゼを吸着させ、ついで0.3〜
0.35M NaClにて溶出する方法である。この方法
は、デオキシリボヌクレアーゼを特異的に吸着
溶離する利点を有するものの、DNA−
Sepharoseを緩衝化するPHがデオキシリボヌクレ
アーゼの至適PHの約7.5で行なつているので、
DNA−SepharoseのDNAを基質として分解して
しまうためにDNA−Sepharoseの再利用が困難
となること等の欠点が有り、このままでは到底工
業化は不可能な精製方法であつた。
In recent years, affinity chromatography has been developed as a means of enzyme purification, and there are examples of attempts to apply affinity chromatography to purify deoxyribonuclease from the pancreas. Namely, JCSchabort, Journal of
In the method described in Chromatography., Vol. 73, 253-256 (1972), deoxyribonucleic acid-immobilized agarose (hereinafter referred to as
Deoxyribonuclease is adsorbed using DNA-Sepharose, and then
This is a method of elution with 0.35M NaCl. Although this method has the advantage of specifically adsorbing and eluating deoxyribonuclease,
Since the pH for buffering Sepharose is approximately 7.5, which is the optimum pH for deoxyribonuclease,
This purification method had drawbacks such as difficulty in reusing DNA-Sepharose because the DNA of DNA-Sepharose was degraded as a substrate, and it was impossible to commercialize the purification method as it was.

そこで本発明者らは、アフイニテイクロマトグ
ラフイーによる精製法の利点を生かしつつ、上記
欠点を解消するために種々検討した結果、デオキ
シリボヌクレアーゼ活性の著しく低下するPH4
〜5で、DNA−Sepharoseにデオキシリボヌク
レアーゼを吸着せしめたところ、意外にも、こ
のPH範囲の方が、PH7.5においてよりもはるかに
吸着能が高く、そしてイオン強度0.3以下での溶
離はみられず、かつDNAを基質として分解しな
いので、DNA−Sepharoseを精製手段として、
繰り返し利用出来ることが判り本発明を完成した
ものである。
Therefore, the present inventors conducted various studies in order to eliminate the above drawbacks while taking advantage of the advantages of the purification method by affinity chromatography.
When deoxyribonuclease was adsorbed onto DNA-Sepharose at pH 5.5, it was surprisingly found that the adsorption capacity was much higher in this pH range than at pH 7.5, and elution at ionic strengths below 0.3 was inhibited. DNA-Sepharose can be used as a purification method because it is not degraded and does not degrade using DNA as a substrate.
The present invention has been completed because it has been found that it can be used repeatedly.

即ち本発明は、哺乳動物膵臓抽出物含有液と、
DNA−Sepharoseとを、酸性下、好ましくはPH
4ないしPH5で接触せしめ、哺乳動物膵臓抽出物
含有液中のデオキシリボヌクレアーゼを該
DNA−Sepharoseに吸着せしめた後、0.3〜1.0M
塩化カリウムにて、該DNA−Sepharoseからデ
オキシリボヌクレアーゼを溶出せしめることを
特徴とするデオキシリボヌクレアーゼの精製方
法であり、その特長とする点は、酸性下、特にPH
ないしPH5でDNA−Sepharoseと哺乳動物膵臓
抽出物含有液を接触せしめているので、含有する
デオキシリボヌクレアーゼの吸着および溶離後
のDNA−Sepharoseを簡単な洗浄のみで繰り返
し使用出来ることにある。
That is, the present invention provides a solution containing a mammalian pancreas extract;
DNA-Sepharose under acidic conditions, preferably PH
4 to PH5 to detect the deoxyribonuclease in the mammalian pancreatic extract-containing solution.
After adsorbing to DNA-Sepharose, 0.3-1.0M
This is a method for purifying deoxyribonuclease, which is characterized by eluting the deoxyribonuclease from the DNA-Sepharose with potassium chloride.
Since the DNA-Sepharose is brought into contact with the mammalian pancreatic extract-containing solution at pH 5, the DNA-Sepharose after adsorption and elution of the deoxyribonuclease contained therein can be used repeatedly with only simple washing.

そしてこのDNA−Sepharoseはデオキシリボ
ヌクレアーゼを特異的に吸着するのであるが、
膵臓中に含まれる他の酵素、例えばトリプシン、
リボヌクレアーゼ等はほとんど吸着しないので、
膵臓含有液からデオキシリボヌクレアーゼのみ
を簡単に単離出来るのである。
This DNA-Sepharose specifically adsorbs deoxyribonuclease.
Other enzymes contained in the pancreas, such as trypsin,
Since ribonuclease etc. are hardly adsorbed,
Only deoxyribonuclease can be easily isolated from pancreatic fluid.

本発明において、使用するDNA−Sepharose
の調整はArndt−jovinらの方法(Donna J.
Arndtjovin et al European Journal of
Biochemistry54、411(1975))による。そして
又、DNA−SepharoseをPH4ないし5にて緩衝
化して使用するが、この場合の緩衝液としては酢
酸緩衝液、クエン酸緩衝液等いずれにてもよい
が、デオキシリボヌクレアーゼの作用を出来る
だけ抑制するのに都合のよいクエン酸緩衝液を用
いるのが好ましい。さらにDNA−Sepharoseに
吸着したデオキシリボヌクレアーゼの溶出に用
いる塩溶液としては0.3以上のイオン強度を有す
ればいずれにても使用可能である。
In the present invention, DNA-Sepharose used
The adjustment was performed using the method of Arndt-jovin et al. (Donna J.
Arndtjovin et al European Journal of
Biochemistry 54 , 411 (1975)). Also, DNA-Sepharose is used after being buffered at pH 4 to 5. In this case, the buffer may be an acetate buffer, a citrate buffer, etc., but the action of deoxyribonuclease is suppressed as much as possible. It is preferable to use a citrate buffer, which is convenient for this purpose. Furthermore, any salt solution can be used as long as it has an ionic strength of 0.3 or more as the salt solution used to elute the deoxyribonuclease adsorbed on DNA-Sepharose.

次に本発明の実施例について述べるが、試験例
及び実施例で用いる酵素活性の測定法は次の通り
である。
Next, examples of the present invention will be described, and the enzyme activity measurement method used in the test examples and examples is as follows.

1 デオキシリボヌクレアーゼ活性 リンドベルグ(U.Lindberg)の方法〔ビイ
オキミカ・エト・ビイオフイジカ・アクタ
(Biochimica et Biophysica Acta)82巻、
237頁(1964年)〕に準じて、デオキシリボ核酸
(DNA)の分解活性260nmの吸光度の増加によ
り測定した。
1 Deoxyribonuclease activity U.Lindberg's method [Biochimica et Biophysica Acta, Vol. 82,
237 (1964)], the deoxyribonucleic acid (DNA) decomposition activity was measured by the increase in absorbance at 260 nm.

2 トリプシン活性 フムメル(B.C.W.Hummel)の方法〔カナ
デイアン・ジヤーナル・オブ・バイオケミスト
リー・アンド・バイオフイジツクス
(Canadian Journal of Biochemistry and
Biophysics)37巻、1393頁(1959年)〕に準じ
て、P−トルエンスルホニル−L−アルギニ
ン・メチルエステル(P−toluenesulfonyl−
L−arginine methlester)の分解活性を
247nmの吸光度の増加により測定した。
2 Trypsin activity BCWHummel's method [Canadian Journal of Biochemistry and Biophysics]
P-toluenesulfonyl-L-arginine methyl ester (P-toluenesulfonyl-L-arginine methyl ester)
Degradation activity of L-arginine methlester)
Measured by increase in absorbance at 247 nm.

3 リボヌクレアーゼ活性 M.R.McDonaldらの方法〔Metbod in
Enzymology Vol2、427〜436(1955)〕に準じ
てリボ核酸(RNA)の分離活性を260nmの吸
光度の増加により測定した。
3 Ribonuclease activity MRMcDonald et al. method [Metbod in
Enzymology Vol. 2, 427-436 (1955)], the ribonucleic acid (RNA) separation activity was measured by the increase in absorbance at 260 nm.

試験例 1 0.2%ネオペプトンを含む100mM Britton−
Robinsonの広域緩衝液9mlでPH3〜10まで緩衝
化したDNA−Sepharose1g(Wet weight)に
0.5mlのデオキシリボヌクレアーゼ(シグマ社
製)溶液(1mg/ml)を室温にて加え、5分撹拌
後、上澄のデオキシリボヌクレアーゼ活性およ
びDNA−Sepharoseに吸着したデオキシリボヌ
クレアーゼ活性(但し1M KClで該吸着体から
溶出した後、抽出液に回収される活性)をそれぞ
れ測定したところ第1図の如き結果が得られた。
Test example 1 100mM Britton- containing 0.2% neopeptone
Add 1 g of DNA-Sepharose (wet weight) buffered to pH 3-10 with 9 ml of Robinson's broad-spectrum buffer.
Add 0.5 ml of deoxyribonuclease (manufactured by Sigma) solution (1 mg/ml) at room temperature, and after stirring for 5 minutes, remove the deoxyribonuclease activity of the supernatant and the deoxyribonuclease activity adsorbed on DNA-Sepharose (however, 1M KCl will reduce the adsorption). The activity recovered in the extract after being eluted from the body was measured, and the results shown in Figure 1 were obtained.

第1図より明らかの如く、PH5.5以下において
DNA−Sepharoseとデオキシリボヌクレアーゼ
の吸着力は大であるが、PH6以上においては、
デオキシリボヌクレアーゼによつてDNAが分
解されるため両者の吸着力はみかけ上低下してい
ることがわかる。
As is clear from Figure 1, below PH5.5
The adsorption power of DNA-Sepharose and deoxyribonuclease is large, but at pH 6 or above,
It can be seen that because DNA is degraded by deoxyribonuclease, the adsorption power between the two is apparently reduced.

実施例 1 豚生膵臓1Kgをミンチ後、1の水に懸濁さ
せ、4℃で一夜放置後、6N−酢酸でPH4.0とし、
過によつて沈澱を除き、抽出液600mlを得た。
一方0.2%ネオペプトンを含む50mMクエン酸緩
衝液(PH4.0)であらかじめ平衡化した100mlの
DNA−Sepharoseカラムに上記抽出液200mlを通
液し、デオキシリボヌクレアーゼを吸着させた
後、更に同緩衝液を流すことにより、該抽出液中
に含まれるデオキシリボヌクレアーゼ以外の蛋
白質であるトリプシンおよびリボヌクレアーゼ等
を洗い出した後、0.3Mおよび1.0M塩化カリウム
を用いてDNA−Sepharoseカラムに吸着してい
るデオキシリボヌクレアーゼを溶出せしめる。
該溶出液中には300万単位のデオキシリボヌクレ
アーゼが含まれており、比活性は約110倍に上
昇した。そしてこのものの豚性膵臓抽出液からの
回収率は94%であり、トリプシン、リボヌクレア
ーゼ活性はほとんど含んでいなかつた。
Example 1 1 kg of raw pig pancreas was minced, suspended in 1 water, left overnight at 4°C, adjusted to pH 4.0 with 6N-acetic acid,
The precipitate was removed by filtration to obtain 600 ml of an extract.
Meanwhile, 100 ml of pre-equilibrated with 50 mM citrate buffer (PH4.0) containing 0.2% neopeptone.
After passing 200 ml of the above extract through a DNA-Sepharose column to adsorb deoxyribonuclease, the same buffer solution is passed through the column to remove proteins other than deoxyribonuclease, such as trypsin and ribonuclease contained in the extract. After washing, the deoxyribonuclease adsorbed on the DNA-Sepharose column is eluted using 0.3M and 1.0M potassium chloride.
The eluate contained 3 million units of deoxyribonuclease, and the specific activity increased approximately 110 times. The recovery rate of this product from the porcine pancreas extract was 94%, and it contained almost no trypsin or ribonuclease activity.

ここにおける溶出パターンが第2図に示され
る。
The elution pattern here is shown in FIG.

実施例 2 豚膵臓脱脂粉末200gを2の水に懸濁させ、
6N−酢酸でPHを4.0とし、4℃で3時間抽出後、
抽出残渣を過によつて除き、抽出液2を得
た。一方あらかじめ0.2%ネオペプトンを含む
50mMクエン酸緩衝液(PH4)であらかじめ平衡
化した100mlのDNA−Sepharoseカラムに上記抽
出液600mlを通液し、デオキシリボヌクレアーゼ
を吸着させた後、同緩衝液を流すことにより該
抽出液中に含まれるデオキシリボヌクレアーゼ
以外の蛋白質であるトリプシン等を洗い出した後
1.0M塩化カリウム溶液にて該吸着体からデオキ
シリボヌクレアーゼを溶出せしめる。該溶出区
分中には抽出液中のデオキシリボヌクレアーゼ
の94%が回収され、総括性は350万単位である。
さらに該DNA−Sepharoseカラムを0.2%ネオペ
プトンを含む50mMクエン酸緩衝液(PH4.0)で
洗浄し、ついで上記豚膵臓脱脂粉末よりの抽出液
600mlを前回と同様に通液し、デオキシリボヌク
レアーゼを吸着させ、さらに同緩衝液を流し、
トリプシン等の夾雑蛋白質を洗い出した後、
1.0M塩化カリウム溶液にて該カラムからデオキ
シリボヌクレアーゼを溶出せしめる。この溶出
液中にはデオキシリボヌクレアーゼが95%の収
率で回収され、かつ総括性は360万単位であつた。
Example 2 200g of defatted pork pancreas powder was suspended in 2 water,
After adjusting the pH to 4.0 with 6N-acetic acid and extracting at 4°C for 3 hours,
The extraction residue was removed by filtration to obtain extract 2. Meanwhile, pre-contains 0.2% neopeptone
600 ml of the above extract was passed through a 100 ml DNA-Sepharose column equilibrated in advance with 50 mM citrate buffer (PH4) to adsorb deoxyribonuclease, and then the same buffer was passed through it to remove the DNase contained in the extract. After washing out trypsin, which is a protein other than deoxyribonuclease,
Deoxyribonuclease is eluted from the adsorbent with 1.0 M potassium chloride solution. In the elution section, 94% of the deoxyribonuclease in the extract was recovered, with a totality of 3.5 million units.
Furthermore, the DNA-Sepharose column was washed with 50mM citrate buffer (PH4.0) containing 0.2% neopeptone, and then the extract from the defatted pig pancreas powder was
Pour 600 ml in the same way as before to adsorb deoxyribonuclease, then pour the same buffer solution,
After washing out contaminant proteins such as trypsin,
Deoxyribonuclease is eluted from the column with 1.0M potassium chloride solution. Deoxyribonuclease was recovered in this eluate with a yield of 95%, and the totality was 3.6 million units.

こうして繰り返しカラムを使用することが出来
る。
This allows repeated columns to be used.

ここにおける溶出パターンが第3図に示され
る。
The elution pattern here is shown in FIG.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は試験例1における、各PHにおける
DNA−Sepharoseのデオキシリボヌクレアーゼ
吸着をみた図で、第2図は実施例1における溶
出パターンを示す図で、第3図は実施例2におけ
る溶出パターンを示す図である。 A…上澄み液、B…1M KClによる溶出液、C
…トリプシン、D…RNase、E…デオキシリボ
ヌクレアーゼ、F…豚性膵臓抽出液。
Figure 1 shows the results at each PH in Test Example 1.
FIG. 2 is a diagram showing the elution pattern in Example 1, and FIG. 3 is a diagram showing the elution pattern in Example 2. FIG. A...Supernatant liquid, B...Eluate with 1M KCl, C
...Trypsin, D...RNase, E...Deoxyribonuclease, F...Porcine pancreas extract.

Claims (1)

【特許請求の範囲】 1 哺乳動物膵臓抽出物含有液とデオキシリボ核
酸固定化アガロースとを、酸性下、好ましくは約
PH4〜5の条件下で接触せしめてデオキシリボヌ
クレアーゼを吸着せしめ、しかる後、イオン強
度を上昇させてデオキシリボヌクレアーゼを溶
出せしめることを特徴とするデオキシリボヌクレ
アーゼの精製方法。 2 デオキシリボヌクレアーゼの吸着がクエン
酸緩衝液の存在下で行なわれる特許請求の範囲第
1項記載の方法。
[Claims] 1. A solution containing a mammalian pancreatic extract and deoxyribonucleic acid-immobilized agarose are heated under acidic conditions, preferably about
1. A method for purifying deoxyribonuclease, which comprises adsorbing deoxyribonuclease by contacting under conditions of pH 4 to 5, and then eluting deoxyribonuclease by increasing ionic strength. 2. The method according to claim 1, wherein the adsorption of deoxyribonuclease is carried out in the presence of a citrate buffer.
JP3843879A 1979-04-02 1979-04-02 Purification of deoxyribonuclease i Granted JPS55131389A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3843879A JPS55131389A (en) 1979-04-02 1979-04-02 Purification of deoxyribonuclease i

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3843879A JPS55131389A (en) 1979-04-02 1979-04-02 Purification of deoxyribonuclease i

Publications (2)

Publication Number Publication Date
JPS55131389A JPS55131389A (en) 1980-10-13
JPS6317436B2 true JPS6317436B2 (en) 1988-04-13

Family

ID=12525299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3843879A Granted JPS55131389A (en) 1979-04-02 1979-04-02 Purification of deoxyribonuclease i

Country Status (1)

Country Link
JP (1) JPS55131389A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449968B1 (en) * 1988-12-23 1999-02-24 Genentech, Inc. Process for the preparation of human dnase

Also Published As

Publication number Publication date
JPS55131389A (en) 1980-10-13

Similar Documents

Publication Publication Date Title
KR0139209B1 (en) Method for the purification of protein
Cuatrecasas et al. Selective enzyme purification by affinity chromatography.
Steers et al. The purification of β-galactosidase from Escherichia coli by affinity chromatography
De La Hoz et al. A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase
Remy et al. Purification of yeast phenylalanyl-tRNA synthetase by affinity chromatography, on a tRNAPhe-sepharose column
JPH04228072A (en) Lipopeptideacylase
EP0092845B1 (en) Process for purifying enzyme
Ramseyer et al. The use of affinity chromatography in purification of cyclic nucleotide receptor proteins
Chaga et al. Isolation and characterization of catalase from Penicillium chrysogenum
JPS6317436B2 (en)
Dunn et al. Purification of Escherichia coli alkaline phosphatase on an ion-exchange high-performance liquid chromatographic column using carboxymethyl dextrans
von der Haar [11] Affinity elution: Principles and applications to purification of aminoacyl-tRNA synthetases
US20090093038A1 (en) Method for the production of pure virally inactivated butyrylcholinesterase
Markey Rapid purification fo deoxyribonuclease I using fast protein liquid chromatography
EP0244147A2 (en) Purification process for hybrid proteins
Pogell et al. [32] Specific elution with substrate
le Goffic et al. Affinity chromatography of β-lactamases
Pietta et al. Improved purification protocol for oxalate oxidase from barley roots
JPS6371174A (en) Purified enzyme and its production
SU1634713A1 (en) Method for preparing restriction endonuclease
RU2036236C1 (en) Method of purification of alkaline phosphatase from seal intestine
RU2051922C1 (en) METHOD OF ISOLATION OF RECOMBINANT INTERLEUKIN-1 β FROM MICROORGANISM BIOMASS
Wilchek et al. [57] Purification of nucleases
JPH0556952B2 (en)
JPH08176199A (en) Method for purifying hirudine by affinity chromatography